AU2213197A - Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor - Google Patents

Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor

Info

Publication number
AU2213197A
AU2213197A AU22131/97A AU2213197A AU2213197A AU 2213197 A AU2213197 A AU 2213197A AU 22131/97 A AU22131/97 A AU 22131/97A AU 2213197 A AU2213197 A AU 2213197A AU 2213197 A AU2213197 A AU 2213197A
Authority
AU
Australia
Prior art keywords
nitric oxide
therapeutic methods
compositions useful
methods employing
useful therefor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22131/97A
Inventor
Ching-San Lai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medinox Inc
Original Assignee
Medinox Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medinox Inc filed Critical Medinox Inc
Publication of AU2213197A publication Critical patent/AU2213197A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU22131/97A 1996-03-05 1997-03-05 Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor Abandoned AU2213197A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1282096P 1996-03-05 1996-03-05
US60012820 1996-03-05
PCT/US1997/004131 WO1997032585A1 (en) 1996-03-05 1997-03-05 Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU69984/98A Division AU722361B2 (en) 1995-11-21 1998-06-09 Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor

Publications (1)

Publication Number Publication Date
AU2213197A true AU2213197A (en) 1997-09-22

Family

ID=21756859

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22131/97A Abandoned AU2213197A (en) 1996-03-05 1997-03-05 Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor

Country Status (4)

Country Link
JP (1) JP2000506170A (en)
AU (1) AU2213197A (en)
CA (1) CA2238029A1 (en)
WO (1) WO1997032585A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0835659T3 (en) * 1996-10-14 2005-04-18 Aventis Pharma Gmbh Use of non-peptidic antagonists for bradykinin in the manufacture of drugs for the treatment and prevention of Alzheimer's disease
WO1999051215A2 (en) * 1998-04-06 1999-10-14 Fujisawa Pharmaceutical Co., Ltd. Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus or cyclosporins
ATE333447T1 (en) * 1998-06-01 2006-08-15 Shionogi & Co CYANOIMINOCHINOXALINE DERIVATIVES
US6093743A (en) 1998-06-23 2000-07-25 Medinox Inc. Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
US6265420B1 (en) 1998-06-23 2001-07-24 Medinox, Inc. Use of nitric oxide scavengers to treat side effects caused by therapeutic administration of sources of nitric oxide
US6596770B2 (en) 2000-05-05 2003-07-22 Medinox, Inc. Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
GB9903404D0 (en) * 1999-02-16 1999-04-07 Angiogene Pharm Ltd Methods of treatment and compositions useful for the treatment of diseases involving angiogenesis
GB9908175D0 (en) * 1999-04-09 1999-06-02 Lilly Co Eli Method of treating neurological disorders
US6274627B1 (en) 1999-10-12 2001-08-14 Medinox, Inc. Conjugates of dithiocarbamate disulfides with pharmacologically active agents and uses therefor
US6271228B1 (en) * 2000-04-28 2001-08-07 Pfizer Inc. Blood pressure stabilization during hemodialysis
DE10230752A1 (en) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg New drug compositions based on magnesium salts and fibrinolytics
EP1531825A2 (en) * 2002-08-29 2005-05-25 University Of Southampton Use of apoptosis inducing agents in the preparation of a medicament for the treatment of liver diseases
WO2008038302A2 (en) * 2006-09-26 2008-04-03 Jegannathan Srinivas Therapeutic formulation comprising a sulfonylurea, metformin and a nitric oxide scavenger.
WO2009052376A1 (en) 2007-10-18 2009-04-23 Musc Foundation For Research Development Methods for the diagnosis of genitourinary cancer

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5426046A (en) * 1983-11-08 1995-06-20 The Board Of Trustees Of The Leland Stanford Junior University Human monoclonal antibody to lipid A of gram negative bacteria
US5137889A (en) * 1983-12-02 1992-08-11 Otsuka Pharmaceutical Co., Ltd. Dihydropyridine derivatives and process for preparing the same
US4686100A (en) * 1985-04-02 1987-08-11 The Board Of Trustees Of The Leland Stanford Junior University Method for the treatment of adult respiratory distress syndrome
WO1989001772A1 (en) * 1987-09-03 1989-03-09 University Of Georgia Research Foundation, Inc. Ocular cyclosporin composition
US5294430A (en) * 1988-09-12 1994-03-15 University Of Rochester Use of dithiocarbamates to treat myelosuppression
US5176908A (en) * 1988-12-19 1993-01-05 American Cyanamid Company Method for the treatment of endotoxic shock in mammal
US5100899A (en) * 1989-06-06 1992-03-31 Roy Calne Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof
US5530141A (en) * 1992-03-04 1996-06-25 Center For Innovative Technology 2,4-diaryl-1,3-dithiolanes; 2,4-diaryl-1,3-dioxolanes; 2,4-diaryl-1,3-oxathiolanes; and 2,5-diaryl-1,3-oxathiolanes for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5460954A (en) * 1992-04-01 1995-10-24 Cheil Foods & Chemicals, Inc. Production of human proinsulin using a novel vector system
AU3803593A (en) * 1992-04-02 1993-11-08 Smithkline Beecham Corporation Compounds
US5317040A (en) * 1993-01-26 1994-05-31 Washington University Method for the treatment of pertussis with aminoguanidine
US5436265A (en) * 1993-11-12 1995-07-25 Merck Frosst Canada, Inc. 1-aroyl-3-indolyl alkanoic acids and derivatives thereof useful as anti-inflammatory agents

Also Published As

Publication number Publication date
JP2000506170A (en) 2000-05-23
WO1997032585A1 (en) 1997-09-12
CA2238029A1 (en) 1997-09-12

Similar Documents

Publication Publication Date Title
AU7678496A (en) Combinational therapeutic methods employing nitric oxide scavengers
AU7819994A (en) Nitric oxide treatment
AU7323294A (en) Perfluoroelastomeric compositions and methods
AU7564694A (en) Erection-inducing methods and compositions
GB2310855B (en) Substituted phenylbisacylphosphine oxides and photoinitiator mixtures
AU5565599A (en) Chemically modified saponins and the use thereof as adjuvants
AU3691793A (en) Gas well treatment compositions and methods
AUPM871994A0 (en) Mini syringe and carry case
HK1045640A1 (en) Novel use of nitric oxide
AU2349399A (en) R-lansoprazole compositions and methods
AU2213197A (en) Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor
AU2972597A (en) Compositions and uses thereof
AU8967998A (en) Antibiotic-ligand conjugates and methods of use thereof
AU4215399A (en) Dermatological compositions and methods
AU7401598A (en) Epoxide-amine dendrimers and the preparation and use thereof
AU4006695A (en) Calcineurin interacting protein compositions and methods
AU6528494A (en) Nitric oxide combination therapy
IL127152A0 (en) Methods of increasing nitric oxide synthesis
AU3674595A (en) Antianemic agent containing iron and difructose
AU3200197A (en) New composition and methods
AU8473398A (en) 1,3-diaza- heterocycles and their use as nitric oxide synthase inhibitors
AU1829097A (en) Methods for regenerating scarless skin and compositions used therein
AU6998498A (en) Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor
AU4018395A (en) Compounding elements and use thereof
AU3868495A (en) Acrolein-releasing composition and use thereof